Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin. Common interactions include amnesia among females and deep vein thrombosis among males.

The phase IV clinical study analyzes what interactions people who take Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin have. It is created by eHealthMe based on reports of 18 people who take Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

18 people who take Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin together, and have interactions are studied.


What is Heparin sodium 10,000 units in sodium chloride 0.45%?

Heparin sodium 10,000 units in sodium chloride 0.45% has active ingredients of heparin sodium. eHealthMe is studying from 53 Heparin sodium 10,000 units in sodium chloride 0.45% users for its effectiveness, alternative drugs and more.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 552,713 Aspirin users for its effectiveness, alternative drugs and more.

Number of Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin reports submitted per year:

Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin drug interactions.

Common Heparin Sodium 10,000 Units In Sodium Chloride 0.45% and Aspirin drug interactions by gender *:

female:

  1. Amnesia
  2. Anaemia
  3. Blood fibrinogen decreased
  4. Cardiac failure congestive
  5. Cellulitis
  6. Cerebrovascular accident
  7. Coagulopathy
  8. Cyanosis
  9. Diarrhoea
  10. Dysphagia

male:

  1. Deep vein thrombosis
  2. Hypotension
  3. Confusional state
  4. Dyspnoea
  5. Headache
  6. Heparin-induced thrombocytopenia
  7. Renal failure chronic
  8. Ventricular tachycardia
  9. Pyrexia
  10. Arterial thrombosis limb

Common Heparin Sodium 10,000 Units In Sodium Chloride 0.45% and Aspirin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Acute hepatic failure
  2. Arterial thrombosis limb
  3. Atrophy
  4. Blister
  5. Cardiogenic shock
  6. Cerebral infarction
  7. Deep vein thrombosis
  8. Fluid overload
  9. Heparin-induced thrombocytopenia
  10. Hypersensitivity

30-39:

  1. Arterial thrombosis limb
  2. Cardiac arrest
  3. Haemodynamic instability
  4. Hypotension
  5. Respiratory arrest
  6. Vascular pseudoaneurysm
  7. Abdominal pain
  8. Aneurysm arteriovenous
  9. Arteriovenous fistula aneurysm
  10. Dyspnoea

40-49:

  1. Abdominal pain
  2. Anaemia
  3. Diarrhoea
  4. Dyspnoea
  5. Heparin-induced thrombocytopenia
  6. Acute respiratory distress syndrome
  7. Amnesia
  8. Blood fibrinogen decreased
  9. Cardiac failure congestive
  10. Cellulitis

50-59:

  1. Encephalopathy
  2. Erythema
  3. Eye swelling
  4. Gastrointestinal haemorrhage
  5. Haematoma
  6. Haemolysis
  7. Heart rate increased
  8. Hepatic failure
  9. Hypoxic-ischaemic encephalopathy
  10. Impaired healing

60+:

  1. Cardiac arrest
  2. Confusional state
  3. Headache
  4. Hyperhidrosis
  5. Hypotension
  6. Lethargy
  7. Loss of consciousness
  8. Nasal congestion
  9. Nasopharyngitis
  10. Nausea

Common conditions people have *:

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 22.22%
  2. Thrombolysis (resolving the blood clot): 2 people, 11.11%
  3. Pain: 2 people, 11.11%
  4. Nausea (feeling of having an urge to vomit): 2 people, 11.11%
  5. High Blood Pressure: 2 people, 11.11%
  6. Acute Myocardial Infarction (acute heart attack): 2 people, 11.11%
  7. Stress And Anxiety: 1 person, 5.56%
  8. Sedation: 1 person, 5.56%
  9. Local Anaesthesia: 1 person, 5.56%
  10. Leukocytosis (increased white blood cells): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aspirin interactions:

Browse all interactions between Aspirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium and aspirin (the active ingredients of Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin, respectively), and Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Heparin sodium 10,000 units in sodium chloride 0.45% and Aspirin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: